PharmaLex Expands Integrated Market Access Expertise through Merger with MAP Group

PharmaLex Group has announced on Jan. 18, 2022, that is has merged with MAP Group, an Italian provider of market access services. Through this merger, PharmaLex broadens its market access expertise and extends its reach into the Italian marketplace.

MAP Group was founded in 2010 and comprises three companies—MA Provider, MAPCOM Consulting, and 3P Solution. The group specializes in highly innovative products, such as advanced therapeutic medicinal products (ATMPs) under development for rare diseases and oncology, and is a leading member of the ATMP forum.

“The merger with PharmaLex perfectly complements our service offerings by leveraging our strong local market knowledge and expertise while providing our clients with broader reach across Europe,” said Elena Paola Lanati, MAP Group CEO and founder, in the company press release. “We share common principles and values with PharmaLex, in particular to help our clients navigate an increasingly complex legislative and commercial marketplace. In addition, the merger with PharmaLex provides an opportunity for our talented people to expand their careers in a broader global marketplace.”

“We are delighted to welcome the MAP Group team to the PharmaLex Group, and we are excited about the opportunity that the merger gives us to further expand our offerings in market access, brand communications, and educational services,” added PharmaLex CEO Thomas Dobmeyer, in the press release. “The merger also enables us to extend our footprint in the important Italian marketplace, adding to our strong existing team in Milan, which provides regulatory, safety, and quality services to local clients. PharmaLex first established an office in Italy 2017 and has since built a strong local footprint. Through the merger with the MAP Group, we are further strengthening our team, allowing us to support clients throughout the product lifecycle in order to deliver exceptional, tailor-made results.”

Source: PharmaLex